Found 35 matching trials
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease PHASE1 CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Show More Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases EARLY_PHASE1 This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Learn More & Join Trial
Universal CAR-T Cells Targeting Multiple Myeloma PHASE1 The aim of this study is to assess the feasibility, safety and efficacy of ...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia EARLY_PHASE1 This is an investigator-initiated trial to evaluate the safety and efficacy...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease EARLY_PHASE1 This is an exploratory, open-label, single-arm clinical study designed to e...
Show More Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis EARLY_PHASE1 This is an open label, single-site, dose-escalation study in up to 18 parti...
Show More Location
The first affiliated hospital of medical college of zhejiang university
Learn More & Join Trial
CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy. PHASE1 This is an investigator-initiated trial to evaluate the safety and efficacy...
Show More Location
Regenerative Medicine Center and Red Blood Cell Disorders Center
Learn More & Join Trial
A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus PHASE1 This study is a single-arm, open-label clinical study designed to evaluate ...
Show More Location
The First Affiliated Hospital of Ustc Anhui Provincial Hospital
Learn More & Join Trial
An Exploratory Clinical Study on the Safety and Efficacy of Anti-CD19/BCMA U CAR-T Cells in the Treatment of Relapsed/Refractory Immune-mediated Kidney Disease EARLY_PHASE1 A single arm, open-label pilot study is designed to determine the safety an...
Show More Location
Changhai Hospital
Learn More & Join Trial
Universal CAR-T Cell Injection Targeting CD19/BCMA in Patients With Inflammatory Bowel Disease EARLY_PHASE1 This is an open-label, Phase I, investigator-initiated trial (IIT) designed...
Show More Location
Union Hospital, Tongji Medical College, Huazhong Univerdity of Science and Technology
Learn More & Join Trial